Full Text Journal Articles by
Author Erika Mohr Holland

Advertisement

Find full text journal articles








Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic.

Erika Mohr-Holland, Bianca Douglas-Jones, Ivy Apolisi, Noluvo Ngambu, Shaheed Mathee, Rabia Cariem, Vanessa Mudaly, Colin Pfaff, Petros Isaakidis, Jennifer Furin, Anja Reuter,

Lancet Child Adolesc Health (The Lancet. Child & adolescent health)
[2021, 5(3):159-161]

Cited: 0 times

View full text PDF listing >>



How COVID-19 could benefit tuberculosis and HIV services in South Africa.

Claire Keene, Erika Mohr-Holland, Tali Cassidy, Vera Scott, Aurelie Nelson, Jennifer Furin, Laura TriviƱo-Duran,

Lancet Respir Med (The Lancet. Respiratory medicine)
[2020, 8(9):844-846]

Cited: 2 times

View full text PDF listing >>



Advertisement

Correspondence regarding "Delamanid for rifampicin-resistant tuberculosis: a retrospective study from South Africa".

Erika Mohr-Holland, Anja Reuter, Jennifer Hughes, Johnny Daniels, Busisiwe Beko, Goodman Makhanda, Virginia De Avezedo, Yulene Kock, Helen Cox, Jennifer Furin, Laura Trivino Duran, Petros Isaakidis, Gabriella Ferlazzo,

Eur Respir J (The European respiratory journal)
[2020, 56(1):]

Cited: 0 times

View full text PDF listing >>



Injectable-free regimens containing bedaquiline, delamanid, or both for adolescents with rifampicin-resistant tuberculosis in Khayelitsha, South Africa.

Erika Mohr-Holland, Anja Reuter, Jennifer Furin, Anthony Garcia-Prats, Virginia De Azevedo, Vanessa Mudaly, Yulene Kock, Laura Trivino-Duran, Petros Isaakidis, Jennifer Hughes,

Background:Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10-19 years) with injectable-free regimens containing these drugs in Khayelitsha, South Africa. Methods:This retrospective study included adolescents initiating injectable-free RR-TB treatment regimens containing bedaquiline and/or delamanid from February ... Read more >>

EClinicalMedicine (EClinicalMedicine)
[2020, 20:100290]

Cited: 0 times

View full text PDF listing >>





Advertisement

Disclaimer
0.567 s